"We offer the right solution for all active ingredients, therapeutic areas and production requirements," says Holger Krenz, Global Vice President Business Development High Value Products Tubular Glass, "The new performance levels give our customers a transparent overview of our portfolio, making it easier to choose the right product." There are three performance levels within each product category: Gx Value, Gx Advance and Gx Elite. They make it easier for pharmaceutical and biotech companies to choose the right product platform for the specific requirements of the active pharmaceutical ingredient or the area of application. The Gx Elite product version offers the highest quality and is particularly suitable for innovative biopharmaceutical drugs. Find the right solution for your needs! Learn more about: https://lnkd.in/evAEfY-2 #innovatingforabetterlife #vails #syringes #ampoules #cartrigdes #pharma #biotech #drugpackaging
Info
Gerresheimer is the innovative system and solution provider and global partner for the pharma and biotech industry. The company offers a comprehensive portfolio of pharmaceutical containment solutions, drug delivery systems and medical devices as well as solutions for the health and cosmetics industry. The product range includes digital solutions for therapy support, medication pumps, syringes, pens, auto-injectors and inhalers as well as vials, ampoules, tablet containers, dropper bottles, other bottles and more. Gerresheimer ensures the safe delivery and administration of drugs to the patient. With 36 production sites in 16 countries in Europe, America and Asia, Gerresheimer has a global presence and produces locally for the regional markets. With over 11,000 employees, the company generated revenues of around €1.82bn in 2022. Gerresheimer AG is listed in the MDAX on the Frankfurt Stock Exchange (ISIN: DE000A0LD6E6). Gerresheimer ist als innovativer System- und Lösungsanbieter der globale Partner für die Pharma- und Biotech-Branche. Das Unternehmen bietet ein umfassendes Portfolio von Containment Solutions für Medikamente, Drug Delivery Systemen und Medizinprodukten sowie Lösungen für die Gesundheits- und Kosmetikbranche an. Das Leistungsspektrum umfasst unter anderem digitale Lösungen für die Therapiebegleitung, Medikamentenpumpen, Spritzen, Pens, Autoinjektoren und Inhalatoren sowie Injektionsfläschchen, Ampullen, Tablettenbehälter, Tropfflaschen und andere Flaschen. Gerresheimer sorgt dafür, dass Medikamente sicher zum Patienten gelangen und verabreicht werden können. Mit 36 Produktionsstandorten in 16 Ländern in Europa, Amerika und Asien ist Gerresheimer weltweit präsent und produziert vor Ort für die regionalen Märkte. Mit über 11.000 Mitarbeitenden erwirtschaftete das Unternehmen 2022 einen Umsatz von rund 1,82 Mrd. Euro. Die Gerresheimer AG notiert im MDAX an der Frankfurter Wertpapierbörse (ISIN: DE000A0LD6E6).
- Website
-
http://www.gerresheimer.com
Externer Link zu Gerresheimer
- Branche
- Arzneimittelherstellung
- Größe
- 10.001+ Beschäftigte
- Hauptsitz
- Düsseldorf
- Art
- Kapitalgesellschaft (AG, GmbH, UG etc.)
- Gegründet
- 1864
- Spezialgebiete
- Plastics & Devices, Primary Packaging Glass, Advanced Technologies, Drug Delivery, Patch Pump, Medical Devices, Primary Packaging Plastic, Drug Reconstitution, Injection Devices, Liquid Drug Delivery, Pharmaceutical, Cosmetic, Micro Pump, Primary Packaging Plastic, Inhalation und Traceability
Orte
-
Primär
Klaus-Bungert-Str. 4
Düsseldorf, 40468, DE
Beschäftigte von Gerresheimer
Updates
-
We cordially invite you to visit us at ADLM 2024 Clinical Lab Expo, the premier global laboratory medicine exposition, booth #1568, in Chicago. There you will have the opportunity to experience how we turn your visions into market-ready products using various laboratory disposables and medical devices. Gerresheimer Medical Systems is your one-stop-shop that can help you accelerate your time to market for any medical device. Use promo code “43148E” for your free clinical lab expo pass: https://lnkd.in/gabUT87H. We look forward to seeing you in Chicago and discussing your next diagnostic project. #innovatingforabetterlife #adlm #medicaldevices #laboratorydisposables
-
-
We will publish our half-year report on our website on July 11 in the morning at 7 am CEST: https://lnkd.in/e8dQc6At
-
-
What is the purpose in regards to the requested amounts? Gerresheimer is proud to be your partner regardless of whether you look for a packaging for clinical trials, a niche market, or high-quantity market. Knowing the requested amounts helps our product selector g guide, which combines state-of-the-art online customer service with the expertise of the Gerresheimer team in a digital tool, to leads you to your perfect packaging solution. Click here to check it out! https://lnkd.in/eennw2NG #innovatingforabetterlife #productselector #gguide #sales #pharma #biotech #biopharma #veterinary
-
-
Gerresheimer Syringes for Ophthalmic: More than meets the eye. Did you know, that Gerresheimer is the preferred partner in the area of ophthalmic injectables offering the broadest portfolio of syringe configurations made of glass and polymers, metal-free or tungsten-reduced, either as baked-on-siliconized or silicone-oil-free options? Comprehensive testing data available on request: https://lnkd.in/d3BNkiVS #innovatingforabetterlife #ophthalmic #injectables #pharma #biotech
-
We won 3rd place for “Best Investor Relations MDAX” in this year’s “German Investor Relations Award" (Deutscher Investor Relations Preis)! Institutional Investor, WirtschaftsWoche and the DIRK – Deutscher Investor Relations Verband, the German Investor Relations Association, award the prestigious prize for outstanding investor relations work in Germany. The awards are based on Institutional Investor's Europe Executive Team which collects independent feedback on the IR work of listed companies from thousands of buy- and sell-side professionals worldwide. Thanks to all analysts and investment professionals who voted for our Gerresheimer IR team! The award is both an incentive and an obligation for us. Great work Guido Pickert, Thomas Rosenke, Maurizio Mazza! #innovatingforabetterlife #investorrelations
-
-
Am 11.Juli.2024 ist Tag der Ausbildung in Frammersbach und wir sind natürlich wieder dabei! Komm vorbei und entdecke die vielfältigen und spannenden Ausbildungsmöglichkeiten bei #Gerresheimer! 🚀 Wann: 11.07.2024 , 8:00-13:00 Uhr Wo: Festzelt Marktplatz, 97833 Frammersbach Wir freuen uns auf dich! 😊 #Azubi #Ausbildung #Karriere #Glasproduktion #Job
-
-
The conventional aseptic fill & finish process for vials and cartridges hides operational costs generated by inefficiencies of upstream operations (washing and depyrogenation). Both processes are known to cause defects like breakage or particle contamination at primary packaging containers. By transitioning to Ready-To-Use (RTU) solutions, these inefficiencies can be effectively eliminated by process design: RTU fill & finish lines using pre-sterilized products does not need any washing or depyrogenation providing a streamlined fill & finish process with a reduced number of defect modes. RTU technology not only mitigates the risk of container damage but also helps to reduce investment cost with a simplified fill & finish process. Embracing RTU technology is a strategic move towards investment optimization with flexible cost configurations, easy-to scale processes, refocus on core pipeline activities and superior product quality in aseptic manufacturing. Learn more about Gx® RTF Vials: https://lnkd.in/eD2wqQ4e #innovatingforabetterlife #tco #vials #rtu #rtf #pharma #biologics #drugdelivery
-
-
Damien McKeon and Sueyoung Yoon discuss the trends driving interest in subcutaneous administration, the barriers to overcome and the characteristics of a #patient-centric solution. Ongoing advances in drug development are bringing to market highly targeted therapies for treating #cancer or #autoimmune disorders that can be administered subcutaneously instead of intravenously. Subcutaneous injection offers advantages that include faster and less invasive administration, and the potential to facilitate patient self-administration. That said, factors such as resistance to change, disruption of patient flows through the health system and the difficulty of addressing highly variable side effects may stand in the way of adoption. #innovatingforabetterlife #subcutaneousadministration #drugdelivery #pharma #biotech https://lnkd.in/e9YqbGxc
-
After 28 years of dedicated service to our company, Gerresheimer bids farewell to a valued executive Niels During Pedersen as he has decided to seek new adventures as investor and advisor. “Over the years, Niels' strategic vision has been instrumental in numerous global projects and initiatives that have significantly influenced the growth and success of our company. I would like to thank Niels most sincerely for his many years of service, his commitment, and his continued loyalty to Gerresheimer. Above all, I wish him good health and personal well-being in his new phase of life”, says our CEO Dietmar Siemssen. Niels During joined the plastics industry in January 1996. He became Managing Director and shareholder of Dudek Plast in Vaerloese, Denmark. Following the acquisition of Dudek Plast by Superfos, he was appointed CEO of the Plastic Division. Since Gerresheimer acquired the company in 2006, Niels has successfully led our primary packaging plastics business unit. After the Gerresheimer acquisition of Dudek Plast on January 1, 2006, Niels took lead in creating Primary Packaging Plastics. In this period the company developed from a Northern Europe focused firm to a true global player with 10 plants in 4 continents. Under the umbrella of the leadership development program “Quarterback”, Niels and his team developed a clear strategy, culture, and values within Primary Packaging Plastics. His Gerresheimer journey has been marked by numerous achievements and contributions that have left an indelible mark on our company. We would like to thank Niels for his 28 years of dedication and commitment to our company and wish him all the best for the future. #innovatingforabetterlife #farewell #packaging #pharma #cosmetics
-
Ähnliche Seiten
Jobs durchsuchen
Finanzierung
Letzte Runde
Kapitalerhöhung nach Börsengang298.080.912,00 $